The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 801–900 of 1,010
Lee, S., Rivera, O. C., & Kelleher, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.794461 · Cited by 38
Igarashi, A., Itoh, K., Yamada, T., Adachi, Y., Kato, T., Murata, D., Sesaki, H., & Iijima, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002356 · Cited by 33
Macrocephaly: Solving the Diagnostic Dilemma
Tan, A. P., Mankad, K., Gonçalves, F. G., Talenti, G., & Egloff, A. M. (2018) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000170 · Cited by 40
“31 that acts as downregulator of the PI3K/AKT/mTOR pathway.(85,86) The PTEN hamartoma tumor syndrome (PHTS) is an umbrella term that encompasses several clinical syndromes related to germline mutations in the PTEN tumor suppressor gene,(87) associated with overgrowth of connective tissue and multiple hamartomas with a…”
BackgroundBresin, A., Cristofoletti, C., Caprini, E., Cantonetti, M., Monopoli, A., Russo, G., & Narducci, M. G. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.08.454 · Cited by 32
Peng, H., Yang, H., Xiang, X., & Li, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8263 · Cited by 41
Zhu, H., Du, F., & Cao, C. (2020) · Cell Biology International · doi:10.1002/cbin.11473 · Cited by 31
Changes of pro-inflammatory and anti-inflammatory macrophages after peripheral nerve injury
Zhang, F., Miao, Y., Liu, Q., Li, S., & He, J. (2020) · RSC Advances · doi:10.1039/d0ra06607a · Cited by 34
Recent advances in PTEN signalling axes in cancer
Chow, J. T.-S., & Salmena, L. (2020) · Faculty Reviews · doi:10.12703/r/9-31 · Cited by 37
Self-citationComputational Modeling of the Metabolic States Regulated by the Kinase Akt
Mosca, E., Alfieri, R. R., Maj, C., Bevilacqua, A., Canti, G. L., & Milanesi, L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00418 · Cited by 35
PTEN inhibits AMPK to control collective migration
Péglion, F., Capuana, L., Perfettini, I., Boucontet, L., Braithwaite, B., Colucci‐Guyon, E., Quissac, E., Forsberg‐Nilsson, K., Llense, F., & Etienne‐Manneville, S. (2022) · Nature Communications · doi:10.1038/s41467-022-31842-y · Cited by 35
Regulation of autophagic flux by CHIP
Guo, D., Ying, Z., Wang, H., Chen, D., Gao, F., Ren, H., & Wang, G. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1543-7 · Cited by 33
Ju, H., Han, K., Lee, J. D., & Ro, S. W. (2015) · International Journal of Cancer · doi:10.1002/ijc.29703 · Cited by 38
Timsah, Z., Ahmed, Z., Ivan, C., Berrout, J., Gagea, M., Zhou, Y., Armaiz-Peña, G. N., Hu, X., Vallien, C., Kingsley, C. V., et al. (2015) · Oncogene · doi:10.1038/onc.2015.279 · Cited by 32
Gil, A., Rodríguez‐Escudero, I., Stumpf, M., Molina, M., Cid, V. J., & Pulido, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119287 · Cited by 37
Human serum miR-34a as an indicator of exposure to ionizing radiation
Halimi, M., Shahabi, A., Moslemi, D., Parsian, H., Asghari, S. M., Sariri, R., Yeganeh, F., & Zabihi, E. (2016) · Radiation and Environmental Biophysics · doi:10.1007/s00411-016-0661-6 · Cited by 31
Zhou, L., Bu, Y., Liang, Y., Zhang, F., Zhang, H., & Li, S. (2016) · Medical Science Monitor · doi:10.12659/msm.897306 · Cited by 34
Breast cancer genetics in young women: What do we know?
Gómez‐Flores‐Ramos, L., Álvarez-Gómez, R. M., Villarreal-Garza, C. M., Wegman-Ostrosky, T., & Mohar, A. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.08.001 · Cited by 41
Chen, Y., Zhu, D., Gao, J., Xu, Z., Tao, S., Yin, W., Zhang, Y., Gao, Y., & Zhang, C. (2019) · FEBS Journal · doi:10.1111/febs.14754 · Cited by 31
Sevdali, E., Block, V., Lataretu, M., Li, H., Smulski, C. R., Briem, J.-S., Heitz, Y., Fischer, B., Ramirez, N.-J., Grimbacher, B., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111019 · Cited by 36
Keshavarzmotamed, A., Mousavi, V., Masihipour, N., Rahmati, A., Dehmordi, R. M., Ghezelbash, B., Alimohammadi, M., & Mafi, A. (2023) · Current Molecular Pharmacology · doi:10.2174/0118761429249717230920113227 · Cited by 45
Molecular Pathways: PI3K Pathway Phosphatases as Biomarkers for Cancer Prognosis and Therapy
Chen, M., Nowak, D. G., & Trotman, L. C. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3680 · Cited by 32
Recent Progress in Mouse Models for Tumor Suppressor Genes and its Implications in Human Cancer
Inoue, K., Fry, E. A., & Taneja, P. (2013) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s10358 · Cited by 32
Signal transduction via the T cell antigen receptor in naïve and effector/memory T cells
Kannan, A., Huang, W., Huang, F., & August, A. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.023 · Cited by 37
The role of microRNA in metastatic processes of non-small cell lung carcinoma
Pastorkova, Z., Škarda, J., & Andel, J. (2016) · Biomedical Papers · doi:10.5507/bp.2016.021 · Cited by 30
Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis
Weidle, U. H., Birzele, F., Kollmorgen, G., & Nopora, A. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20061 · Cited by 32
ZKSCAN3 promotes breast cancer cell proliferation, migration and invasion
Chi, Y., Han, X., Wang, F., Chen, X., Shan, Z., Sun, Y., & Fan, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.019 · Cited by 30
WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
Ertay, A., Liu, H., Liu, D., Peng, P., Hill, C. N., Xiong, H., Hancock, D. C., Yuan, X., Przewloka, M. R., Coldwell, M. J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03210-5 · Cited by 55
Pal, D., Rai, A., Checker, R., Patwardhan, R. S., Singh, B., Sharma, D., & Sandur, S. K. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108890 · Cited by 30
Genomics of human congenital hydrocephalus
Kundishora, A. J., Singh, A. K., Allington, G., Duy, P. Q., Ryou, J., Alper, S. L., Jin, S. C., & Kahle, K. T. (2021) · Child s Nervous System · doi:10.1007/s00381-021-05230-8 · Cited by 31
Giraldo, E., Nebot, V. J., Đorđević, S., Requejo-Aguilar, R., Alastrue‐Agudo, A., Zagorodko, O., Armiñán, A., Martínez-Rojas, B., Vicent, M. J., & Moreno‐Manzano, V. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121052 · Cited by 31
Alterations in TGFβ signaling during prostate cancer progression.
Elliott, B., Johnson, R., & Khan, S. A. (2021) · American Journal of Clinical and Experimental Urology · Cited by 47
The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment
Cessna, H., Baritaki, S., Zaravinos, A., & Bonavida, B. (2022) · Cancers · doi:10.3390/cancers14194596 · Cited by 29
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions
Vidalle, M. C., Sheth, B., Fazio, A., Marvi, M. V., Leto, S., Koufi, F., Neri, I., Casalin, I., Ramazzotti, G., Follo, M. Y., et al. (2023) · Biomolecules · doi:10.3390/biom13071049 · Cited by 31
McCann, M. J., Rowland, I. R., & Roy, N. C. (2014) · Nutrients · doi:10.3390/nu6114839 · Cited by 30
Effect of the PTEN gene on adhesion, invasion and metastasis of osteosarcoma cells
Hu, Y., Xu, S., Jin, W., Yi, Q., & Wei, W. (2014) · Oncology Reports · doi:10.3892/or.2014.3362 · Cited by 30
Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer
Bellone, M., & Elia, A. R. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.002 · Cited by 35
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo
Caserta, E., Egriboz, O., Wang, H., Martin, C. K., Koivisto, C. S., Pécot, T., Kladney, R. D., Shen, C., Shim, K.-S., Pham, T., et al. (2015) · Genes & Development · doi:10.1101/gad.262568.115 · Cited by 29
Prognostic factors in malignant pleural mesothelioma
Davidson, B. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.02.006 · Cited by 37
Snail Is a Critical Mediator of Invadosome Formation and Joint Degradation in Arthritis
Lauzier, A., Lavoie, R. R., Charbonneau, M., Gouin-Boisvert, B., Harper, K., & Dubois, C. M. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.10.021 · Cited by 29
Inhibition of Rad51 sensitizes breast cancer cells with wild-type PTEN to olaparib
Zhao, Q., Guan, J., Zhang, Z., Lv, J., Wang, Y., Liu, L., Zhou, Q., & Mao, W. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.090 · Cited by 30
Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network
Inoue, K., & Fry, E. A. (2018) · Cancer Investigation · doi:10.1080/07357907.2018.1533965 · Cited by 27
Dai, C., Wu, B., Chen, Y., Li, X., Bai, Y., Du, Y., Pang, Y., Wang, Y. T., & Dong, Z. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00757-4 · Cited by 32
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Choi, S. W., Lee, Y., Shin, K., Koo, H., Kim, D., Sa, J. K., Cho, H. J., Shin, H.-M., Lee, S. J., Kim, H., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03657-0 · Cited by 33
Kishikawa, T., Higuchi, H., Wang, L., Panch, N., Maymi, V., Best, S., Lee, S., Notoya, G., Toker, A., Matesic, L. E., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140436 · Cited by 32
“PTEN dynamics at the plasma membrane has been recently shown to represent a critical on/off switch toward PI3K activation (5, 6).”
Self-citationThe Role of PTEN-L in Modulating PINK1-Parkin-Mediated Mitophagy
Eldeeb, M. A., Esmaili, M., Hassan, M., & Ragheb, M. A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00475-w · Cited by 34
Naryzhnaya, N. V., Маслов, Л. Н., Popov, S. V., Mukhomedzyanov, А. V., Ryabov, V. V., Kurbatov, B. K., Gombozhapova, A. E., Singh, N., Fu, F., Pei, J., et al. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220123 · Cited by 30
Romaus‐Sanjurjo, D., Saikia, J. M., Kim, J. M., Tsai, K. M., Le, G. Q., & Zheng, B. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01186-z · Cited by 34
“Neither eEF1A1 overexpression nor eEF1A2 overexpression increases the level of pAKT in CST neurons Given that AKT is involved in both the activation of the mTOR signaling [28] and actin remodeling [16], we examined the levels of AKT activation following eEF1A and PTEN manipulations.”
BackgroundDeng, J., Wang, H., Liang, Y., Zhao, L., Li, Y., Yan, Y., Zhao, H., Zhang, X., & Zou, F. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110517 · Cited by 29
Synthetic lethal approaches to target cancers with loss of PTEN function
Ertay, A., Ewing, R. M., & Wang, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.12.015 · Cited by 30
SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts
Edimo, W. E., Vanderwinden, J., & Erneux, C. (2012) · Advances in Biological Regulation · doi:10.1016/j.jbior.2012.09.003 · Cited by 31
Ndfip1 represses cell proliferation by controlling Pten localization and signaling specificity
Howitt, J. A., Low, L., Putz, U., Doan, A., Lackovic, J., Goh, C., Gunnersen, J. M., Silke, J., & Tan, S. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv020 · Cited by 31
Differential regulation and synthetic lethality of exclusive RB1 and CDKN2A mutations in lung cancer
Kim, N., Song, M., Kim, S., SEO, Y., Kim, Y., & Yoon, S. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3262 · Cited by 30
Self-citationMicrofluidics: Rapid Diagnosis for Breast Cancer
Panesar, S., & Neethirajan, S. R. (2016) · Nano-Micro Letters · doi:10.1007/s40820-015-0079-8 · Cited by 33
Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway
Getahun, A., Wemlinger, S. M., Rudra, P., Santiago, M. L., van Dyk, L. F., & Cambier, J. C. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160972 · Cited by 30
Positive diversifying selection is a pervasive adaptive force throughout the Drosophila radiation
Cicconardi, F., Marcatili, P., Arthofer, W., Schlick-Steiner, B. C., & Steiner, F. M. (2017) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2017.04.023 · Cited by 27
Lemma, S. A., Kuusisto, M. E. L., Haapasaari, K., Sormunen, R. T., Lehtinen, T., Klaavuniemi, T., Eray, M., Jantunen, E., Soini, Y., Vasala, K., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx061 · Cited by 29
Lai, J., Li, S., Shi, X., Coyne, J., Zhao, N., Dong, F., Mao, Y., & Wang, Y. (2017) · Chemical Science · doi:10.1039/c7sc03023a · Cited by 30
Forrester, J. V., Dick, A. D., McMenamin, P. G., Roberts, F., & Pearlman, E. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-7020-5554-6.00004-6 · Cited by 31
Seo, M., Lee, S., Kim, J., Lee, W., Hu, G., Elledge, S. J., & Suk, K. (2014) · Nature Communications · doi:10.1038/ncomms6217 · Cited by 31
PTEN Mouse Models of Cancer Initiation and Progression
Lee, Y.-R., & Pandolfi, P. P. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037283 · Cited by 32
Self-citationSetia, S., Nehru, B., & Sanyal, S. N. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.07.006 · Cited by 31
de Assis, L. V. M., & Isoldi, M. C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1210-4 · Cited by 32
The Intricate Interplay between Mechanisms Underlying Aging and Cancer
Piano, A., & Titorenko, V. I. (2014) · Aging and Disease · doi:10.14336/ad.2014.0209 · Cited by 30
Quattrone, A., Woźniak, A., Dewaele, B., Floris, G., Vanspauwen, V., Looy, T. V., Schöffski, P., Rutkowski, P. L., Sciot, R., & Dêbiec‐Rychter, M. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.53 · Cited by 32
The tumor suppressor PTEN and the PDK1 kinase regulate formation of the columnar neural epithelium
Grego‐Bessa, J., Bloomekatz, J. E., Castel, P., Omelchenko, T., Baselga, J. M., & Anderson, K. V. (2016) · eLife · doi:10.7554/elife.12034 · Cited by 35
The roles of microRNAs related with progression and metastasis in human cancers
Liu, H., & Gao, P. (2016) · Tumor Biology · doi:10.1007/s13277-016-5436-9 · Cited by 28
Over-Expression of miR-21 and Lower PTEN Levels in Wilms’ Tumor with Aggressive Behavior
Cui, M., Liu, W., Zhang, L., Guo, F., Liu, Y., Chen, F., Liu, T., Ma, R., & Wu, R. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.242.43 · Cited by 28
Gowda, C. S., Soliman, M., Kapadia, M. A., Ding, Y., Payne, K. J., & Dovat, S. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.06.001 · Cited by 31
Hyde, P. N., Lustberg, M. B., Miller, V. J., LaFountain, R. A., & Volek, J. S. (2017) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2017.06.001 · Cited by 31
MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer
Emami, S. S., Akbari, A., Zare, A. A., Agah, S., Masoodi, M., Talebi, A., Minaeian, S., Fattahi, A., & Moghadamnia, F. (2018) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-018-0055-x · Cited by 28
FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression
Tong, J., Shen, Y., Chen, X., Wang, R., Hu, Y., Zhang, X., Zhang, Z., & Han, L. (2019) · Oncology Reports · doi:10.3892/or.2019.7259 · Cited by 32
Weidle, U. H., SCHMID, D., Birzele, F., & Brinkmann, U. (2019) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20163 · Cited by 29
Marqués, M., Tranchant, R., Risa-Ebrí, B., Suárez-Solís, M. L., Fernández, L. C., Pau, E. C. D. S., del Pozo, N., de Villarreal, J. M., Meiller, C., Allory, Y., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1633 · Cited by 29
Ye, T., & Liang, B. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152943 · Cited by 33
Brunner, A., Rahmanto, A. S., Johansson, H. J., Franco, M., Viiliäinen, J., Gazi, M., Frings, O., Fredlund, E., Spruck, C., Lehtiö, J., et al. (2020) · eLife · doi:10.7554/elife.57894 · Cited by 30
Yue, F., Song, C., Huang, D., Narayanan, N., Qiu, J., Jia, Z., Yuan, Z., Oprescu, S. N., Roseguini, B. T., Deng, M., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.029 · Cited by 29
Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance
Altschuler, J., Stockert, J. A., & Kyprianou, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042100 · Cited by 30
Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis
Zhang, J., Liu, H., Chen, Y., Liu, H., Zhang, S., Yin, G., & Xie, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1312919 · Cited by 46
“Phosphatase and tensin homolog (PTEN), a tumor suppressor and a phosphatase speci fi c to the 3 ’ position of phosphatidylinositol 3,4,5-triphosphate (195), has a pivotal role in cell metabolism and motility (196).”
BackgroundMir-17∼92 Governs Motor Neuron Subtype Survival by Mediating Nuclear PTEN
Tung, Y.-T., Lu, Y. L., Peng, K.-C., Yen, Y.-P., Chang, M., Li, J., Jung, H., Thams, S., Huang, Y., Hung, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.050 · Cited by 29
Yazlovitskaya, E. M., Tseng, H.-Y., Viquez, O. M., Tu, T., Mernaugh, G., McKee, K. K., Riggins, K. S., Quaranta, V., Pathak, A., Carter, B. D., et al. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-07-1203 · Cited by 28
AKT activation controls cell survival in response to HDAC6 inhibition
Kaliszczak, M. A., Trousil, S., Ali, T., & Aboagye, E. O. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.180 · Cited by 30
Chen, L., Zhang, Y., Li, D., Zhang, N., Liu, R., Han, B., Wei, C., Liu, H., Xu, X., & Hao, J. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.09.008 · Cited by 30
Wang, C., Wang, S., Ma, F.-E., & Zhang, W. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9478 · Cited by 31
Estrella, N. L., Clark, A. L., Desjardins, C. A., Nocco, S. E., & Naya, F. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.666461 · Cited by 31
Liu, H., Du, L., Wang, R., Wei, C., Liu, B., Zhu, L., Liu, P., Liu, Q., Jiang, L., Lu, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3411 · Cited by 27
Benesh, E. C., Humphrey, P. A., Wang, Q., & Moley, K. H. (2013) · Scientific Reports · doi:10.1038/srep03466 · Cited by 28
Sementino, E., Menges, C. W., Kadariya, Y., Peri, S., Xu, J., Liu, Z., Wilkes, R. G., Cai, K. Q., Rauscher, F. J., Klein–Szanto, A. J., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26830 · Cited by 35
Eichner, R., Fernández‐Sáiz, V., Targosz, B., & Bassermann, F. C. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.06.001 · Cited by 32
Wang, H., Zhao, Y., Cao, L., Zhang, J., Wang, Y., & Xu, M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27618 · Cited by 28
Kovalenko, T. F., Morozova, K. V., Ozolinya, L. A., Лапина, И. А., & Patrushev, L. I. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-1-43-50 · Cited by 32
Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma
Ruckert, M. T., de Andrade, P. V., Santos, V. S., & Silveira, V. S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03095-4 · Cited by 28
Liu, P., Wu, L., Chand, H., Li, C., Hu, X., & Li, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118311 · Cited by 28
Liang, X., Qin, C., Yu, G., Guo, X., Cheng, A., Zhang, H., & Wang, Z. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.11.002 · Cited by 28
Nguyen, H.-N., Yang, J.-M., Miyamoto, T., Itoh, K., Rho, E., Zhang, Q., Inoue, T., Devreotes, P. N., Sesaki, H., & Iijima, M. (2015) · Scientific Reports · doi:10.1038/srep12600 · Cited by 31
Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L
Johnston, S. B., & Raines, R. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116898 · Cited by 27
Activated Mutant p110α Causes Endometrial Carcinoma in the Setting of Biallelic Pten Deletion
Joshi, A. R., Miller, C. A., Baker, S. J., & Ellenson, L. H. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.12.019 · Cited by 28
A biosensor to monitor dynamic regulation and function of tumour suppressor PTEN in living cells
Lima‐Fernandes, E., Misticone, S., Boularan, C., Paradis, J. S., Enslen, H., Roux, P. P., Bouvier, M., Baillie, G. S., Marullo, S., & Scott, M. G. H. (2014) · Nature Communications · doi:10.1038/ncomms5431 · Cited by 31
Huaier aqueous extract sensitizes cells to rapamycin and cisplatin through activating mTOR signaling
Hu, Z., Yang, A., Fan, H., Wang, Y., Zhao, Y., Zha, X., Zhang, H., & Tu, P. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.03.069 · Cited by 27
A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation
Restelli, M., Magni, M., Ruscica, V., Pinciroli, P., Cecco, L. D., Buscemi, G., Delia, D., & Zannini, L. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.359 · Cited by 27
A Late G1 Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells
Patel, D., Salloum, D., Saqcena, M., Chatterjee, A., Mroz, V., Ohh, M., & Foster, D. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.757864 · Cited by 27
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.